86 related articles for article (PubMed ID: 32334033)
21. The Impact of Dermatologic Adverse Events on the Quality of Life of Oncology Patients: A Review of the Literature.
Belzer A; Pach JJ; Valido K; Leventhal JS
Am J Clin Dermatol; 2024 May; 25(3):435-445. PubMed ID: 38366030
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety analysis of hypofractionated and conventional fractionated radiotherapy in postoperative breast cancer patients.
Lu Y; Hui B; Yang D; Li Y; Li B; Zhou L; Xu L; Tang F; Wang W; Chen R; Zhao D
BMC Cancer; 2024 Feb; 24(1):181. PubMed ID: 38321381
[TBL] [Abstract][Full Text] [Related]
23. Radiation Dermatitis and Pneumonitis in Patients Irradiated for Breast Cancer.
Eggert MC; Yu NY; Rades D
In Vivo; 2023; 37(6):2654-2661. PubMed ID: 37905621
[TBL] [Abstract][Full Text] [Related]
24. Clinical implementation of deep learning-based automated left breast simultaneous integrated boost radiotherapy treatment planning.
Zeverino M; Piccolo C; Wuethrich D; Jeanneret-Sozzi W; Marguet M; Bourhis J; Bochud F; Moeckli R
Phys Imaging Radiat Oncol; 2023 Oct; 28():100492. PubMed ID: 37780177
[TBL] [Abstract][Full Text] [Related]
25. Cicaderma® in radiation-related dermatitis of breast cancer: Results from the multicentric randomised phase III CICA-RT.
Racadot S; Arnaud A; Schiffler C; Metzger S; Pérol D; Kirova Y
Clin Transl Radiat Oncol; 2023 Jul; 41():100647. PubMed ID: 37441546
[TBL] [Abstract][Full Text] [Related]
26. Implementation of 26 Gy in five fractions over 1 week adjuvant radiotherapy for breast cancer: Prospective report of acute skin toxicity and consideration of resource implications.
Nugent K; Quinlan E; Cleary S; O'Driscoll H; Rohan C; Trousdell J; Williams J; Dunne M; McArdle O; Duane FK
Breast; 2023 Feb; 67():55-61. PubMed ID: 36603414
[TBL] [Abstract][Full Text] [Related]
27. Acute skin toxicity of conventional fractionated versus hypofractionated radiotherapy in breast cancer patients receiving regional node irradiation: the real-life prospective multicenter HYPOBREAST cohort.
Bruand M; Salleron J; Guihard S; Crety CM; Liem X; Pasquier D; Lamrani-Ghaouti A; Charra-Brunaud C; Peiffert D; Clavier JB; Desandes E; Faivre JC
BMC Cancer; 2022 Dec; 22(1):1318. PubMed ID: 36526987
[TBL] [Abstract][Full Text] [Related]
28. Pilot/Phase II Trial of Hypofractionated Radiation Therapy to the Whole Breast Alone Before Breast Conserving Surgery.
Thorpe CS; DeWees TA; Laughlin BS; Vallow LA; Seneviratne D; Pockaj BA; Cronin PA; Halyard MY; Vern-Gross TZ; McGee LA; McLaughlin SA; Voss MM; Golafshar MA; Bulman GF; Vargas CE
Adv Radiat Oncol; 2023; 8(1):101111. PubMed ID: 36483068
[TBL] [Abstract][Full Text] [Related]
29. Shorter Radiation Regimens and Treatment Noncompletion Among Patients With Breast and Prostate Cancer in the United States: An Analysis of Racial Disparities in Access and Quality.
Dee EC; Taunk NK; Chino FL; Deville C; McClelland S; Muralidhar V; McBride SN; Gillespie EF; Yamoah K; Nguyen PL; Mahal BA; Winkfield KM; Vapiwala N; Santos PMG
JCO Oncol Pract; 2023 Feb; 19(2):e197-e212. PubMed ID: 36399692
[TBL] [Abstract][Full Text] [Related]
30. Smoking and Radiation-induced Skin Injury: Analysis of a Multiracial, Multiethnic Prospective Clinical Trial.
Hughes RT; Ip EH; Urbanic JJ; Hu JJ; Weaver KE; Lively MO; Winkfield KM; Shaw EG; Diaz LB; Brown DR; Strasser J; Sears JD; Lesser GJ
Clin Breast Cancer; 2022 Dec; 22(8):762-770. PubMed ID: 36216768
[TBL] [Abstract][Full Text] [Related]
31. Prospective Comparison of Hypofractionated Versus Normofractionated Intensity-Modulated Radiotherapy in Breast Cancer: Late Toxicity Results of the Non-Inferiority KOSIMA Trial (ARO2010-3).
Sarria GR; Welzel G; Polednik M; Wenz F; Abo-Madyan Y
Front Oncol; 2022; 12():824891. PubMed ID: 35600361
[TBL] [Abstract][Full Text] [Related]
32. [Not Available].
da Silva JGB; Costa DT; Cavalcanti IDL; de Britto Lira Nogueira MC; Oliveira DAL
Can Oncol Nurs J; 2022; 32(2):172-181. PubMed ID: 35582251
[TBL] [Abstract][Full Text] [Related]
33. Quality of life in women with breast cancer treated at a radiotherapy centre in Caruaru, Pernambuco, Brazil.
da Silva JGB; Costa DT; Cavalcanti IDL; de Britto Lira Nogueira MC; Oliveira DAL
Can Oncol Nurs J; 2022; 32(2):162-171. PubMed ID: 35582247
[TBL] [Abstract][Full Text] [Related]
34. Favorable safety profile of moderate hypofractionated over normofractionated radiotherapy in breast cancer patients: a multicentric prospective real-life data farming analysis.
Issoufaly I; Petit C; Guihard S; Eugène R; Jung L; Clavier JB; Servagi Vernat S; Bellefqih S; Verret B; Bonnet N; Deutsch É; Rivera S
Radiat Oncol; 2022 Apr; 17(1):80. PubMed ID: 35443729
[TBL] [Abstract][Full Text] [Related]
35. Hypofractionated proton therapy in breast cancer: where are we? A critical review of the literature.
Alterio D; La Rocca E; Volpe S; Camarda AM; Casbarra A; Russell-Edu W; Zerella MA; Orecchia R; Galimberti V; Veronesi P; Leonardi MC; Jereczek-Fossa BA
Breast Cancer Res Treat; 2022 Apr; 192(2):249-263. PubMed ID: 35025004
[TBL] [Abstract][Full Text] [Related]
36. Effect of Heparinoid Moisturizer on Quality of Life in Patients with Acute Radiation Skin Damage Following Hypofractionated Radiation Therapy After Breast-Conserving Surgery: A Randomized Controlled Study.
Kawamori J; Itazawa T; Fukushima S; Ito R; Yamauchi H; Sekiguchi K
Breast Cancer (Dove Med Press); 2021; 13():743-753. PubMed ID: 35002315
[TBL] [Abstract][Full Text] [Related]
37. A clinical trial to compare a 3D-printed bolus with a conventional bolus with the aim of reducing cardiopulmonary exposure in postmastectomy patients with volumetric modulated arc therapy.
Zhang Y; Huang Y; Ding S; Liang J; Kuang J; Mao Q; Ying W; Shu Y; Li J; Jiang C
Cancer Med; 2022 Feb; 11(4):1037-1047. PubMed ID: 34939343
[TBL] [Abstract][Full Text] [Related]
38. A Comprehensive Prospective Comparison of Acute Skin Toxicity after Hypofractionated and Normofractionated Radiation Therapy in Breast Cancer.
Borm KJ; Kleine Vennekate J; Vagedes J; Islam MOA; Duma MN; Loos M; Combs SE; Schiller K; Klusen S; Paepke S; Kiechle MB; Paepke D
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830981
[TBL] [Abstract][Full Text] [Related]
39. Comparing Hypofractionated With Conventional Fractionated Radiotherapy After Breast-Conserving Surgery for Early Breast Cancer: A Meta-Analysis of Randomized Controlled Trials.
Gu L; Dai W; Fu R; Lu H; Shen J; Shi Y; Zhang M; Jiang K; Wu F
Front Oncol; 2021; 11():753209. PubMed ID: 34660318
[TBL] [Abstract][Full Text] [Related]
40. Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost.
Koukourakis IM; Panteliadou M; Giakzidis AG; Nanos C; Abatzoglou I; Giatromanolaki A; Koukourakis MI
Curr Oncol; 2021 Sep; 28(5):3474-3487. PubMed ID: 34590607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
